{"id":24744,"date":"2024-01-26T00:30:00","date_gmt":"2024-01-26T00:30:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4320930_AE20930_0"},"modified":"2024-01-26T00:30:00","modified_gmt":"2024-01-26T00:30:00","slug":"abbvie-expands-biologics-manufacturing-capacity-with-a-223-million-investment-in-singapore-manufacturing-site","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=24744","title":{"rendered":"AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site"},"content":{"rendered":"<br \/>\n<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2155022\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<ul type=\"disc\">\n<li><span class=\"xn-money\">US$223 million<\/span> expansion will add biologics capacity to AbbVie manufacturing network<\/li>\n<li><span class=\"xn-location\">Singapore<\/span> manufacturing site to grow to more than 500 employees following expansion<\/li>\n<li>Construction will commence immediately with facilities becoming operational in 2026<\/li>\n<\/ul>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">SINGAPORE<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Jan. 26, 2024<\/span><\/span> \/PRNewswire\/ &#8212;&nbsp;AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new <span class=\"xn-money\">US$223 million<\/span> (<span class=\"xn-money\">S$301 million<\/span>) expansion of its <span class=\"xn-location\">Singapore<\/span> manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie&#8217;s global network.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder5672\">\n<p style=\"TEXT-ALIGN: center; WIDTH: 100%\"><a href=\"https:\/\/mma.prnasia.com\/media2\/2326849\/AbbVie_Singapore_Groundbreaking.html\" target=\"_blank\" rel=\"nofollow noopener\"><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2326849\/AbbVie_Singapore_Groundbreaking.jpg?p=medium600\" title=\"AbbVie and Singapore Economic Development Board officials participate in a groundbreaking ceremony on Jan. 25 for AbbVie\u2019s $223 million expansion of its Singapore manufacturing site. Once completed, the new expansion will add new biologics manufacturing capacity to AbbVie's global network and more than 100 new jobs in Singapore.\" alt=\"AbbVie and Singapore Economic Development Board officials participate in a groundbreaking ceremony on Jan. 25 for AbbVie\u2019s $223 million expansion of its Singapore manufacturing site. Once completed, the new expansion will add new biologics manufacturing capacity to AbbVie's global network and more than 100 new jobs in Singapore.\" \/><\/a><br \/><span>AbbVie and Singapore Economic Development Board officials participate in a groundbreaking ceremony on Jan. 25 for AbbVie\u2019s $223 million expansion of its Singapore manufacturing site. Once completed, the new expansion will add new biologics manufacturing capacity to AbbVie&#8217;s global network and more than 100 new jobs in Singapore.<\/span><\/p>\n<\/p><\/div>\n<p>Located in <span class=\"xn-location\">Singapore&#8217;s<\/span> Tuas Biomedical Park, AbbVie&#8217;s <span class=\"xn-location\">Singapore<\/span> plant is a state-of-the-art small-molecule and biologics manufacturing facility serving markets worldwide. This new investment will add 24,000 liters of biologics drug-substance capacity to AbbVie&#8217;s global manufacturing network and support current products as well as emerging immunology and oncology compounds within AbbVie&#8217;s pipeline.<\/p>\n<p>&quot;This expansion announcement represents one of AbbVie&#8217;s many investments in its <span class=\"xn-location\">Singapore<\/span>-based operations and the proud continuation of our decade-long partnership with the Government of <span class=\"xn-location\">Singapore<\/span>,&quot; said&nbsp;Azita Saleki-Gerhardt, Ph.D., AbbVie Executive Vice President, Chief Operations Officer. &quot;The expansion of our <span class=\"xn-location\">Singapore<\/span> site will strengthen our global manufacturing capabilities, support our growing biologics pipeline and help AbbVie continue delivering on our patient commitments now and in the future.&quot;<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2374\">\n<\/p><\/div>\n<p>With today&#8217;s announcement, AbbVie has invested more than <span class=\"xn-money\">US$740 million<\/span> (<span class=\"xn-money\">S$1 billion<\/span>) in acquiring, modernizing and expanding its <span class=\"xn-location\">Singapore<\/span> facility over the past 10 years. When fully operational, the expanded <span class=\"xn-location\">Singapore<\/span> manufacturing facility \u2013 AbbVie&#8217;s only manufacturing site in <span class=\"xn-location\">Asia<\/span> \u2013 will employ more than 500 people in manufacturing, quality assurance, supply chain, engineering and administration roles.<\/p>\n<p>&quot;We are delighted that AbbVie has chosen to expand its biologics capacity in <span class=\"xn-location\">Singapore<\/span> for current and future innovative medicines. We are grateful for AbbVie&#8217;s continued trust in the strength of <span class=\"xn-location\">Singapore&#8217;s<\/span> biopharmaceutical manufacturing capabilities and talent base. AbbVie&#8217;s investment will enhance <span class=\"xn-location\">Singapore&#8217;s<\/span> leading advanced manufacturing ecosystem and create exciting job opportunities here,&quot; said <span class=\"xn-person\">Cindy Koh<\/span>, Executive Vice President, Singapore Economic Development Board.<\/p>\n<p>Construction on the expansion will begin later this year, with operations expected to commence in 2026. AbbVie&#8217;s <span class=\"xn-location\">Singapore<\/span> manufacturing plant is a part of AbbVie&#8217;s Operations team, which consists of 14,000 employees working at more than 30 manufacturing, operations and logistics sites across <span class=\"xn-location\">the United States<\/span>, <span class=\"xn-location\">Asia<\/span>, <span class=\"xn-location\">Europe<\/span>, <span class=\"xn-location\">Puerto Rico<\/span> and <span class=\"xn-location\">South America<\/span>.<\/p>\n<p><b>About AbbVie<\/b><\/p>\n<p>AbbVie&#8217;s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people&#8217;s lives across several key therapeutic areas \u2013 immunology, oncology, neuroscience, and eye care \u2013 and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at <a href=\"http:\/\/www.abbvie.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.abbvie.com<\/a>. Follow @abbvie on <a href=\"https:\/\/www.linkedin.com\/company\/abbvie\/\" target=\"_blank\" rel=\"nofollow noopener\">LinkedIn,<\/a> <a href=\"https:\/\/www.facebook.com\/AbbVieGlobal\/\" target=\"_blank\" rel=\"nofollow noopener\">Facebook<\/a>, <a href=\"https:\/\/www.instagram.com\/abbvie\/\" target=\"_blank\" rel=\"nofollow noopener\">Instagram<\/a>, <a href=\"https:\/\/twitter.com\/abbvie\" target=\"_blank\" rel=\"nofollow noopener\">X (formerly Twitter)<\/a>, and <a href=\"https:\/\/www.youtube.com\/user\/AbbVie\" target=\"_blank\" rel=\"nofollow noopener\">YouTube.<\/a><span>&nbsp;<\/span><\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tbody>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><b>Media Contacts<\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">John Torrisi, Director<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+1 (224) 213-0055<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><a href=\"mailto:John.Torrisi@abbvie.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow noopener\">John.Torrisi@abbvie.com<\/a><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Yoosook Kim, Director<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">+82 (02) 3429 9296<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><a href=\"mailto:Yoosook.Kim@abbvie.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow noopener\">Yoosook.Kim@abbvie.com<\/a><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p>&nbsp;<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>US$223 million expansion will add biologics capacity to AbbVie manufacturing network Singapore manufacturing site to grow to more than 500 employees following expansion Construction will commence immediately with facilities becoming operational in 2026 SINGAPORE, Jan. 26, 2024 \/PRNewswire\/ &#8212;&nbsp;AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-24744","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=24744\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site - My Blog\" \/>\n<meta property=\"og:description\" content=\"US$223 million expansion will add biologics capacity to AbbVie manufacturing network Singapore manufacturing site to grow to more than 500 employees following expansion Construction will commence immediately with facilities becoming operational in 2026 SINGAPORE, Jan. 26, 2024 \/PRNewswire\/ &#8212;&nbsp;AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=24744\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-26T00:30:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/2155022\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site\",\"datePublished\":\"2024-01-26T00:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744\"},\"wordCount\":526,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2155022\\\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744\",\"name\":\"AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2155022\\\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600\",\"datePublished\":\"2024-01-26T00:30:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2155022\\\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600\",\"contentUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2155022\\\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=24744#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=24744","og_locale":"en_US","og_type":"article","og_title":"AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site - My Blog","og_description":"US$223 million expansion will add biologics capacity to AbbVie manufacturing network Singapore manufacturing site to grow to more than 500 employees following expansion Construction will commence immediately with facilities becoming operational in 2026 SINGAPORE, Jan. 26, 2024 \/PRNewswire\/ &#8212;&nbsp;AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=24744","og_site_name":"My Blog","article_published_time":"2024-01-26T00:30:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/2155022\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=24744#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=24744"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site","datePublished":"2024-01-26T00:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=24744"},"wordCount":526,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=24744#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2155022\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=24744","url":"https:\/\/transmediavictoria.net.au\/?p=24744","name":"AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=24744#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=24744#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2155022\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600","datePublished":"2024-01-26T00:30:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=24744#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=24744"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=24744#primaryimage","url":"https:\/\/mma.prnasia.com\/media2\/2155022\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600","contentUrl":"https:\/\/mma.prnasia.com\/media2\/2155022\/AbbVieLogo_Preferred_DarkBlue_on_white_Logo.jpg?p=medium600"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=24744#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/24744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24744"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/24744\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}